Literature DB >> 23548492

Does opiate use in traumatically injured individuals worsen pain and psychological outcomes?

Colleen M Trevino1, Terri deRoon-Cassini, Karen Brasel.   

Abstract

UNLABELLED: Opiate use for chronic pain is becoming increasingly controversial. There has been a shift away from supporting the use of opiates for treatment of chronic pain. In addition to lack of effectiveness, concerns for adverse clinical outcomes, addiction, and death have provided the impetus for this change. The purpose of this study was to investigate the percent of trauma patients still using opiates, their pain levels, and psychological outcomes 4 months posttrauma. This was a study to evaluate chronic pain at 4 months posttrauma in 101 participants from a single level 1 trauma center. Eighty of the 101 participants developed chronic pain 4 months after their initial traumatic injury (79%). Of those who developed chronic pain, 27 (26%) were still using opiates. Those using narcotics at 4 months posttrauma had significantly more pain, life interference, depression, and anxiety. Posttraumatic stress disorder (PTSD) was not significantly influenced by narcotic use in this analysis. However, the mean associated with those using narcotics was higher and diagnostic for PTSD. Those taking opiates did not have significantly better relief from their pain using treatments or medications than those not using opiates (F = 8, P = .08). These findings bring into question the appropriate use of opiates for chronic pain and the possible exacerbating effects on pain and psychopathology in traumatically injured patients. PERSPECTIVE: This article identifies data that provide evidence that narcotic pain medication needs to be used carefully in traumatically injured patients with chronic pain, especially in those individuals with comorbid psychological pathology.
Copyright © 2013 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23548492     DOI: 10.1016/j.jpain.2012.12.016

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  11 in total

1.  Goals and Objectives to Optimize the Value of an Acute Pain Service in Perioperative Pain Management.

Authors:  Linda Le-Wendling; Wesley Glick; Patrick Tighe
Journal:  Tech Orthop       Date:  2017-12

Review 2.  The therapeutic potential of interleukin-10 in neuroimmune diseases.

Authors:  A J Kwilasz; P M Grace; P Serbedzija; S F Maier; L R Watkins
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

3.  Pain, Anxiety, and the Continuous Use of Opioids and Benzodiazepines in Trauma Intensive Care Unit Survivors: An Exploratory Study.

Authors:  Carmen Mabel Arroyo-Novoa; Milagros I Figueroa-Ramos; Kathleen A Puntillo
Journal:  P R Health Sci J       Date:  2022-09       Impact factor: 0.600

4.  Opioid use after fracture surgery correlates with pain intensity and satisfaction with pain relief.

Authors:  Arjan G J Bot; Stijn Bekkers; Paul M Arnstein; R Malcolm Smith; David Ring
Journal:  Clin Orthop Relat Res       Date:  2014-04-29       Impact factor: 4.176

5.  Morphine amplifies mechanical allodynia via TLR4 in a rat model of spinal cord injury.

Authors:  Amanda Ellis; Peter M Grace; Julie Wieseler; Jacob Favret; Kendra Springer; Bryce Skarda; Monica Ayala; Mark R Hutchinson; Scott Falci; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2016-08-09       Impact factor: 7.217

Review 6.  Rationale for and approach to preoperative opioid weaning: a preoperative optimization protocol.

Authors:  Heath McAnally
Journal:  Perioper Med (Lond)       Date:  2017-11-22

7.  Chronic pain, posttraumatic stress disorder, and opioid intake: A systematic review.

Authors:  Alicia E López-Martínez; Ángela Reyes-Pérez; Elena Rocío Serrano-Ibáñez; Rosa Esteve; Carmen Ramírez-Maestre
Journal:  World J Clin Cases       Date:  2019-12-26       Impact factor: 1.337

8.  Serum Concentrations of the Endocannabinoid, 2-Arachidonoylglycerol, in the Peri-Trauma Period Are Positively Associated with Chronic Pain Months Later.

Authors:  Colleen M Trevino; Cecilia J Hillard; Aniko Szabo; Terri A deRoon-Cassini
Journal:  Biomedicines       Date:  2022-07-05

9.  Mood and Anxiety Symptoms in Persons Taking Prescription Opioids: A Systematic Review with Meta-Analyses of Longitudinal Studies.

Authors:  Janni Leung; Thomas Santo; Samantha Colledge-Frisby; Tesfa Mekonen; Kate Thomson; Louisa Degenhardt; Jason P Connor; Wayne Hall; Daniel Stjepanović
Journal:  Pain Med       Date:  2022-08-01       Impact factor: 3.637

Review 10.  Strategies aimed at preventing long-term opioid use in trauma and orthopaedic surgery: a scoping review.

Authors:  C Côté; M Bérubé; L Moore; F Lauzier; L Tremblay; E Belzile; M-O Martel; G Pagé; Y Beaulieu; A M Pinard; K Perreault; C Sirois; S Grzelak; A F Turgeon
Journal:  BMC Musculoskelet Disord       Date:  2022-03-11       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.